IQVIA Holdings Inc
NYSE:IQV
Intrinsic Value
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. [ Read More ]
The intrinsic value of one IQV stock under the Base Case scenario is 265.58 USD. Compared to the current market price of 240.84 USD, IQVIA Holdings Inc is Undervalued by 9%.
Valuation Backtest
IQVIA Holdings Inc
Run backtest to discover the historical profit from buying and selling IQV stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
IQVIA Holdings Inc
Current Assets | 5.6B |
Cash & Short-Term Investments | 1.5B |
Receivables | 3.4B |
Other Current Assets | 687m |
Non-Current Assets | 21.1B |
Long-Term Investments | 239m |
PP&E | 819m |
Intangibles | 19.4B |
Other Non-Current Assets | 621m |
Current Liabilities | 6.5B |
Accounts Payable | 3.6B |
Other Current Liabilities | 2.9B |
Non-Current Liabilities | 14.1B |
Long-Term Debt | 13B |
Other Non-Current Liabilities | 1.1B |
Earnings Waterfall
IQVIA Holdings Inc
Revenue
|
15B
USD
|
Cost of Revenue
|
-9.7B
USD
|
Gross Profit
|
5.2B
USD
|
Operating Expenses
|
-3.2B
USD
|
Operating Income
|
2.1B
USD
|
Other Expenses
|
-703m
USD
|
Net Income
|
1.4B
USD
|
Free Cash Flow Analysis
IQVIA Holdings Inc
IQV Profitability Score
Profitability Due Diligence
IQVIA Holdings Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
IQVIA Holdings Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
IQV Solvency Score
Solvency Due Diligence
IQVIA Holdings Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.
Score
IQVIA Holdings Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IQV Price Targets Summary
IQVIA Holdings Inc
According to Wall Street analysts, the average 1-year price target for IQV is 281.34 USD with a low forecast of 237.35 USD and a high forecast of 315 USD.
Ownership
IQV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
IQV Price
IQVIA Holdings Inc
Average Annual Return | 14.06% |
Standard Deviation of Annual Returns | 32.83% |
Max Drawdown | -49% |
Market Capitalization | 43.7B USD |
Shares Outstanding | 182 014 000 |
Percentage of Shares Shorted | 1.82% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 79,000 full-time employees. The company went IPO on 2013-05-09. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.
Contact
IPO
Employees
Officers
The intrinsic value of one IQV stock under the Base Case scenario is 265.58 USD.
Compared to the current market price of 240.84 USD, IQVIA Holdings Inc is Undervalued by 9%.